Thursday, November 24, 2011

White Paper - Optimizing Clinical Research Site Performance through Additive Patient Enrollment

Increases in clinical studies and protocol complexity are putting a strain on sites and their ability to recruit solely within their own walls. Competition for the patients has increased, while fewer patients in a practice are qualifying for contracted studies. Additive Patient Enrollment is an effective solution to meeting enrollment quotas without taking on undue risk or exorbitant expense.

For more information about Acurian, visit http://www.acurian.com/.

See All PharmaVOICE whitepapers

Podcast: Additive Patient Recruitment


In this episode, Roger Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.

For more information about Acurian, visit
www.acurian.com.


Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Optimizing Clinical Research Site Performance through Additive Patient Enrollment

Tuesday, November 15, 2011

White Paper - Creating Strategic Partnerships for Product Development

This white paper delivers key insights into generating effective strategic partnerships for product development initiatives.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

White Paper - No More Product Losers! Strategic Lessons Learned

This white paper explores how to build a successful product strategy by using an analytical framework to evaluate opportunities, solid clinical data, and a careful market assessment to maximize product opportunities and avoid strategic mishaps.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

White Paper - MSL Training: Top 10 Considerations

This white paper discusses the importance of MSL training from developing clinical protocols to building KOL relationships.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

White Paper - In-Depth Analysis of the U.S. Mid-Level Practitioner Market and the Opportunity it Represents

This white paper discusses the Mid-Level Practitioner Market and gives an overview of survey responses of practitioners in the field.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

White Paper - Discovering the Value of KOL Identification & Mapping

This white paper discusses that a well-structured and data-rich mapping of KOLs can yield increased value.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

White Paper - The Power of Clinical Data Gap Analysis

This white paper discusses how analysis of clinical data can be a powerful force in clinical trial management.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

Friday, November 11, 2011

White Paper - Increasing Planning Efficiency in Clinical Development

This whitepaper covers how to improve planning efficiency in the clinical development process. 
For more information about ClearTrial, visit www.cleartrial.com.

Download Whitepaper
Download Related Podcast - Planning for Clinical Trial Conduct in Emerging Locations

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

White Paper - Brazil: The Gem of Latin America

This whitepaper provides an in-depth exploration of Brazil. It illustrates why Brazil's size, demographics, behaviors, and healthcare system make it the most intriguing market in Latin America.
For more information about Kantar Health, visit www.kantarhealth.com.

Download Whitepaper - Brazil: The Gem of Latin America

See All PharmaVOICE whitepapers

Download Related Podcast - Understanding Patients in the Emerging Market of Brazil

Download Podcast Transcript (PDF)

Podcast: Understanding Patients in the Emerging Market of Brazil

In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil. For more information about Kantar Health, visit www.kantarhealth.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Brazil: The Gem of Latin America

Tuesday, October 4, 2011

Podcast: Planning for Clinical Trial Conduct in Emerging Locations

In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit www.cleartrial.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Increasing Planning Efficiency in Clinical Development

Visit http://www.cleartrial.com/

Thursday, September 1, 2011

Podcast: Leveraging Customer Insights to Maximize ROI

In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (CatalystTM) that increases customer ‘acceptance’ (engagement) and drives more people to take action.
div>

Download podcast


See All PharmaVOICE podcasts

White Paper - Improving Trial Efficiencies: Making the Business Case for ePRO

Does ePRO Data Quality Differ from Paper?
Improvements in data quality provided by electronic patient-reported outcome systems are widely reported and accepted throughout the clinical research community. Patient diary data collected electronically is time-stamped, legible and logical with real-time validation provided to patients while entering diary information. ePRO supports multi-site international trials with remote data monitoring via the web with real-time status reporting overall and per site, participant status tracking and on-demand subject randomization.

Download whitepaper


See All PharmaVOICE whitepapers

Tuesday, August 23, 2011

Podcast: Mentoring: A Professional Advantage

In this episode, Laurie Cooke, CEO of the Healthcare Businesswomen's Association, discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.

Download podcast


See All PharmaVOICE podcasts

Tuesday, July 26, 2011

Editor's Take Video: DIA 2011 - Waife & Associates

Thought Leader: Ronald Waife, President

Mr. Waife provides his impressions of the 2011 DIA conference and how business will change over the next few years. For more information, visit http://www.waife.com/

Watch Video

Editor's Take Video: DIA 2011 - Veeva Vault

Thought Leader: Jennifer Goldsmith, VP

This session covers moving R&D to the cloud and the benefits of enterprise content management for clinical trial sponsors. For more information, visit http://www.veevasystems.com/

Watch Video

Editor's Take Video: DIA 2011 - Sentrx

Thought Leader: Michael O'Gorman, President and General Manager

This session covers how the UniPhi platform improves drug safety in pharmacovigilance, challenges with collecting and reporting adverse events, and how to overcome these challenges. For more information, visit http://www.sentrx.com/

Watch Video

Editor's Take Video: DIA 2011 - SAFE-BioPharma Association

Thought Leader: Mollie Shields-Uehling, President and CEO

This session covers why life sciences professionals need a digital identity credential and how to obtain one. For more information, visit http://www.safe-biopharma.org/

Watch Video

Editor's Take Video: DIA 2011 - REGISTRAT-MAPI

Thought Leader: Stephen Webb, President, North America

This session covers measurement-based care, collecting and disseminating data for clinicians, and aligning with pay-for-performance and comparitive effectiveness research. For more information, visit http://www.registratmapi.com/

Watch Video

Editor's Take Video: DIA 2011 - QualityMetric

Thought Leader: Bill Gwinn, VP, Clinical Informatics Solutions

This session covers how to find quality clinical trial investigators, how to evaluate investigators, and using questionaires during the evaluation process. For more information, visit http://www.qualitymetric.com/

Watch Video

Editor's Take Video: DIA 2011 - PAREXEL International

Thought Leader: Neal Mantick, Senior Director, Global Observational Research

This session covers the latest challenges when moving from development to commercialization, and how observational studies differ from clinical trials from a regulatory perspective. For more information, visit http://www.parexel.com/

Watch Video

Editor's Take Video: DIA 2011 - Nextrials

Thought Leader: Jim Rogers, CEO

This session covers trends in Nextrial's integrated EDC/EHR capture platform, and the benefits of adding design tools to the platform. For more information, visit http://www.nextrials.com/

Watch Video

Editor's Take Video: DIA 2011 - Medidata Solutions Worldwide

Thought Leader: Glen de Vries, President

This session covers recent changes in drug development, challenges in the end-to-end clinical process, and using business analytics in the clinical trial process. For more information, visit http://www.mdsol.com/

Watch Video

Editor's Take Video: DIA 2011 - INC Research

Thought Leader: John Fontenault, Global Head and Executive Director, Clinical Data Management & Technology

This session covers the complexities of EDC integration, selecting the features and functionality of EDC tools, and managing customer expectations. For more information, visit http://www.incresearch.com/

Watch Video

Editor's Take Video: DIA 2011 - ICON Clinical Research

Thought Leaders: Jonathan Goldman, Executive VP Strategic Development and Alan Morgan, President

This session covers some overarching trends affecting global drug development and ICON's new partnership with Pfizer. For more information, visit http://www.icon.com/

Watch Video

Editor's Take Video: DIA 2011 - Formedix

Thought Leader: Mark Wheeldon, CEO

This session covers using an integrated software platform to save time and money on clinical trials and integrating CDISC into the drug development process. For more information, visit http://www.formedix.com/

Watch Video

Editor's Take Video: DIA 2011 - ERT

Thought Leader: John Blakeley, Executive VP and Chief Commercial Officer

This session covers multi-modality solutions in the ePro market, and some best practices for selecting an ePro tool. For more information, visit http://www.ert.com/

Watch Video

Editor's Take Video: DIA 2011 - Cmed

Thought Leader: Jim Haughwout, VP of Commercialization and Operations

This session covers how mobile devices and tablets are reshaping clinical trials, the reactions from physicians, and using technology to improve the startup time of clinical trials. For more information, visit http://www.cmedtechnology.com/

Watch Video

Editor's Take Video: DIA 2011 - Chiltern

Thought Leader: Jim Esinhart, Senior Executive VP, Global Scientific Services

This session covers how technological advances are streamlining the drug development process, and how large registries can benefit from a stage-based approach. For more information, visit http://www.chiltern.com/

Watch Video

Webinar - FCPA and Pharma/Life Sciences: Prove Compliance, Avoid Prosecution

The prosecution of global businesses under the Foreign Corrupt Practices Act (FCPA) is on the rise, with Pharmaceutical and Life Sciences companies at the top of the DOJ's list for investigations. Recently, a Pharma and Life Sciences company agreed to pay $70 million in FCPA penalties.

Date Recorded: 06/29/2011  Sponsored by: Aravo
Speaker: William P. Barry, Partner, Richards Kibbe & Orbe LLP

View OnDemand Webinar

All PharmaVOICE Webinars

White Paper - Asia-Pacific Reimbursement Markets

Gerson Lehrman Group, Inc. conducted a survey of nearly 50 physicians across Asia-Pacific to find out their drug prescribing preferences and hospital/formulary influences when considering foreign original branded therapies compared with local generic therapies. Respondents represented opinions from three distinct reimbursement markets: reimbursed, semi-reimbursed and self-pay markets.

Provided by: G+, part of Gerson Lehrman Group, Inc.

Download Whitepaper

All PharmaVOICE White Papers

Monday, July 25, 2011

Editor's Take Video: DIA 2011 - BioClinica

Thought Leader: Peter Benton, Executive VP and President, eClinical Solutions

This session covers the Trident IWR platform and other hot trends in the eClinical solutions space. For more information, visit http://www.bioclinica.com/

Watch Video

Editor's Take Video: DIA 2011 - BBK & PatientsLikeMe

Thought Leaders: Bonnie A. Brescia, Founding Principal, BBK and David Williams, Chief Marketing Officer, PatientsLikeMe

This session covers how the partnership between BBK worldwide, a patient recruitment company, and PatientsLikeMe, an online patient community, improves the patient recruitment process. For more information, visit http://www.bbkworldwide.com/

Watch Video

Editor's Take Video: DIA 2011 - Aptiv Solutions

Thought Leader: Patrick Donnelly, Chairman & CEO

This session covers the origin of Aptiv solutions, and selecting adpative trials as a differentiator for the service providor. For more information, visit http://www.aptivsolutions.com/

Watch Video

Whitepaper - Unlock the Power of Influence with KeyMD

Influential physicians are critical to a company's and a brand's success. Influence mapping, once done informally, is now considered an essential standard practice for enabling commercial strategy. Focusing on uncovering these influencers is key to achieving success in today's challenging new reality. Find out how influence mapping can boost your bottom line by requesting this white paper today.
Download Whitepaper

All PharmaVOICE whitepapers

Download Companion Podcast: Understanding the Power of KOL Influence Mapping

Download Podcast Transcript (PDF)

Monday, June 6, 2011

OnDemand Webinar - Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure

This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.
View Webinar - Galectin-3 Therapy for Heart Failure

All PharmaVOICE Webinars

White Paper - Uncovering the Hidden Opportunity: The Power of Clinical Data Gap Analysis

Learn how a clinical data gap analysis helps companies make the soundest decision with regard to planning for their products and using their precious resources most wisely.

Download White Paper - Uncovering the Hidden Opportunity: The Power of Clinical Data Gap Analysis

All PharmaVOICE whitepapers

White Paper - A Unique Services Model to Support Pharma's Changing Needs

The service industry needs to provide sponsor companies with more creative, innovative approaches and the experience and flexibility they demand. The new business model for providing this support is the functional service provider (FSP) model.
Download White Paper: A Unique Services Model

All PharmaVOICE whitepapers

Tuesday, May 3, 2011

White Paper - Speak on the Dotted Line: Using Voice Biometrics in the Pharmaceutical World

This white paper shows how using Voice Biometrics can be used to securely and safely replace the lengthy paper-based signature processes with real-time voice signatures and the business benefits that can be gleaned

Download White Paper: Speak on the Dotted Line: Using Voice Biometrics in the Pharmaceutical World

Download podcast: Improving Safety, Security, and Speed using Voice Biometrics

Download Podcast Transcript (PDF)

All PharmaVOICE White Papers

White Paper - What Every Clinical Team Should Know about Their Transportation Budgets

When a clinical team is planning a study, they may not appreciate how significant a part of their budget transportation management will consume. Transportation costs account for half of materials management costs and, truth be told, exceed budget more often than not. That’s because the pharmaceutical industry’s efforts to contain transportation costs by making decisions solely on the basis of courier cost are flawed -- and can drive costs up in the long run.

Download White Paper: What Every Clinical Team Should Know about Their Transportation Budgets

Download podcast: The Undercalculated Costs Driving Today's Clinical Trials

Download Podcast Transcript (PDF)

All PharmaVOICE White Papers

Thursday, April 7, 2011

Whitepaper - Discovering the Value of KOL Identification and Mapping

The paper will cover topic such as, targeting the right KOLs for specific roles, determining true KOL influence, allocating MSLs and sales-forces efficiently, and achieving the full benefit of hidden KOL value.

Download Whitepaper

All PharmaVOICE whitepapers

Whitepaper - Conquering the Challenges of Cancer Trial Accrual

This white paper discusses the challenges of finding clinical trial patients for oncology studies.

Click here

All PharmaVOICE whitepapers

Whitepaper - Clinical Labeling: The Benefits of an Approved Phrase Library

This white paper discusses the benefits of an approved phrase library.

Click here

All PharmaVOICE whitepapers

Whitepaper - Unveiling the Potential of the CEE Market

This white paper discusses the growth of the Eastern European market.

Click here

All PharmaVOICE whitepapers

Whitepaper - No More Product Losers! Strategic Lessons Learned

This white paper explores how to build a successful product strategy by using an analytical framework to evaluate opportunities, solid clinical data, and a careful market assessment to maximize product opportunities and avoid strategic mishaps.

Click here

All PharmaVOICE whitepapers

Whitepaper - Cancer Treatment in China: Implications and Opportunities for Pharma in 2011 and Beyond

This white paper discusses the implications and opportunities for cancer treatment in China.

Click here

All PharmaVOICE whitepapers

Whitepaper - Patient-Centered Wellness: Promoting Savings, Accountability and Health

This white paper discusses promoting patient-centered wellness.

Click here

All PharmaVOICE whitepapers

Whitepaper - Maximizing the Success of Your CRO Partnerships

This white paper discusses how to maximize the success of your CRO partnerships.

Click here

All PharmaVOICE whitepapers

Podcast: Oncology Trials: A Novel Approach to Patient Accrual

In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.

Click here

All PharmaVOICE podcasts

Podcast: Streamlining Clinical Trials with an Approved Phrase Library for Labeling

In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.

Click here

All PharmaVOICE podcasts

Podcast: Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals

In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.

Click here

All PharmaVOICE podcasts

Podcast: Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India

In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.

Click here

All PharmaVOICE podcasts

Friday, February 25, 2011

Whitepaper - Increasing Planning Efficiency in Clinical Development

Explore trends and best practices for increasing planning efficiency in clinical development.

Click here

All PharmaVOICE whitepapers

Whitepaper - 3 Critical Elements of CRM in Rare Disorder Marketing

This whitepaper discusses the critical elements of CRM in rare disorder marketing.

Click here

All Pharmavoice whitepapers

Podcast: A New Wellness-Centric Ecosystem

In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.

Click here

All PharmaVOICE podcasts

Podcast: Best Practices for Your CRO Partnerships

In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.

Click here for podcast

Click here for related whitepaper

All PharmaVOICE podcasts

Podcast: Redefining CRM

In this episode, Katie Mihelich and Danielle Jamil provide a redefinition of CRM, and focus in on how it can be used in the rare disorder market space. They'll provide some best practices and key learnings about communicating with the stakeholders in the rare disorder community.

Click here for podcast

Click here for related whitepaper

All PharmaVOICE podcasts

Podcast: How Integrated Solutions Can Optimize Clinical Research

In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline which sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.

Click here

All PharmaVOICE podcasts

Podcast: Unveiling the Potential of the CEE Market

In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.

Click here

All PharmaVOICE podcasts

Wednesday, January 19, 2011

Article - Jan2011 - Using Social Media to Listen Before You Leap

Contributed by Chris Kelly, M.ED., Director, Health Education, and Jeff Greene, Director, Digital Strategy, HealthEd

Click Here

Article - Jan2011 - SHOWCASE FEATURE: Engaging the Empowered E-Patient

The growing consumer use and exchange of online health information is changing the balance of power in the patient-physician relationship.

Click Here

Article - Jan2011 - Quick Response Codes (QR) Codes

The Next Frontier for Pharma

Click Here

Article - Jan2011 - Emerging Market: Olá Brazil

Sponsors are expected to develop better resource planning and forecasting methodologies that rely on more integrated structures with contract research organizations.

Click Here

Article - Jan2011 - Biotech: Raising Capital in a Tight Market

The venture capital environment is in a transition period, slowly recovering from the conditions that have plagued the entire economy.

Click Here

Article - Jan2011 - SFE With a New Business Model

The time is now for the much-talked about move to a consumer-centric sales model.

Click Here

Article - Jan2011 - Achieving Global Launch Excellence

Defining what comprises a global launch is almost as complex as executing a global launch strategy.



Click Here

Wednesday, January 12, 2011

Article - Jan2011 - Millennials: Problems or Prodigies?

Gen Yers entering the workforce will bring disruptive change to the customer work culture, as well as a high level of success.

Read this informative article about the impact Millennials will have on the life sciences industry.

Click here

Article - Jan2011 - Millennials Tailor-made for Sales and Marketing

This generation's natural inclination toward social networking can foster success in today's technologically-enhanced climate.

Click here

Friday, January 7, 2011

Webinar - Pharma Case Study: Driving Business Performance with Customer Experience Solutions

This webcast will feature case studies of 2 leading global pharmas that overhauled their IVR systems to create business value, ROI realized in the process and guidance on how you can build a unified IVR system.

Podcast: China: An Emerging Market for Cancer Therapeutics

In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar Health's latest research on cancer in China.

PharmaVOICE Digital Edition

Everything from the print edition, plus bonus content you won't see in print. Leaf through the pages of our Digital Edition and link directly to companies featured in the magazine.

Click here